{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "NUREXONE BIOLOGIC INC.", "longName": "NurExone Biologic Inc.", "messageBoardId": "finmb_1679703579", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.188, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1663048800000, "priceHint": 4, "epsTrailingTwelveMonths": -0.23, "sharesOutstanding": 42855200, "bookValue": 0.049, "fiftyDayAverage": 0.20178, "fiftyDayAverageChange": -0.013780013, "fiftyDayAverageChangePercent": -0.06829226, "twoHundredDayAverage": 0.24388623, "twoHundredDayAverageChange": -0.05588624, "twoHundredDayAverageChangePercent": -0.2291488, "marketCap": 8070031, "priceToBook": 3.8367348, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.0, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.188, "regularMarketDayRange": "0.187 - 0.188", "regularMarketDayLow": 0.187, "regularMarketVolume": 10000, "regularMarketPreviousClose": 0.188, "bid": 0.187, "ask": 0.226, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.187, "averageDailyVolume3Month": 440, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.06099999, "fiftyTwoWeekLowChangePercent": 0.48031485, "fiftyTwoWeekRange": "0.127 - 0.368", "fiftyTwoWeekHighChange": -0.18, "fiftyTwoWeekHighChangePercent": -0.48913047, "fiftyTwoWeekLow": 0.127, "fiftyTwoWeekHigh": 0.368, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "J90.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1 First Canadian Place", "address2": "Suite 1600 100 King Street West", "city": "Toronto", "state": "ON", "zip": "M5X 1G5", "country": "Canada", "website": "https://nurexone.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NurExone Biologic Inc., a pharmaceutical technology company. It engages in the development of an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yoram  Drucker", "age": 57, "title": "VP of Strategic Devel. & Chairman", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lior  Shaltiel", "title": "CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eran  Ovadya M.B.A.", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Inbar  Paz-Benayoun", "title": "Head of Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eyal  Flom L.L.M., M.B.A.", "age": 56, "title": "Legal Counsel & Director", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Gabriel  Eldor", "title": "VP of Strategic Operations & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ina  Sarel Ph.D.", "title": "Head of CMC, Quality & Regulation", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nirit  Drori-Carmi", "title": "Head of Bioprocess Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}